The following is an excerpt.
Is it right to patent human genes? Both sides in a US law case have sound legal and policy arguments in their favour. But maybe neither is wrong, writes David Galloway.
A legal tussle in the US Supreme Court over who can own gene patents like the breast cancer gene has raised fundamental questions about what can be owned.
While the combatants – the Association for Molecular Pathology and Myriad Genetics – hone their arguments, the rest of us should pause to consider how we got here and whether it’s time to change the law.
Read the full story: Has Science Outgrown Patents?